Modules
Alderbrook Clinical Partners, PLLC
Customer 44961
- Account Classification
- Physician-Office Laboratory
- Classification Confidence
- High
- Sites
- HQ | Vendor
- Assigned Reps
- Raymond Sutter
- Website
- —
- Active Opportunity Count
- 7
- Published Count
- 0
- Revenue Base
- 0
- Known GPBase
- 0
- Analyzer Platforms
- MicroGenics
- Product Groups
- MicroGenics
- Recommended Contact
- Derek Ibsen
- Backup Contact
- —
- Last Meaningful Activity
- 2026-05-21
- Customer Memory
- AI inference: opportunity is based on deterministic order/quote pattern and requires normal rep validation during outreach. Verified transaction fact: platform/product group signal is MicroGenics. Verified item fact: storage requirement Fridge. AI inference: opportunity is based on deterministic order/quote pattern and requires normal rep validation during outreach.
- Evidence References
- Candidate CAND-4a3e115566ab7f804a62c703c6b2abcb41b370b9998b9cc772d09547377beccc | Customer 44961 | Candidate CAND-2f9b2c92d7c66938fc6ca333e8eb2a1019d2846d66664605289bb2e78ca5c523 | Customer 44961 | Order 50709 | Item 11532 | Candidate CAND-50db7eca8fb0fae9f47124055c5207c5da4b9d5039052d5d840bb8408cdc04d8 | Customer 44961 | Order 50710 | Item 11536
Opportunities (11)
| Source Sheet | Report Run ID | Candidate ID | Opportunity ID | Opportunity Series ID | Final Disposition | Assigned Rep | Territory Rep | Source Rep | Customer | Customer ID | Site | City | State | Region | Account Classification | Classification Confidence | Analyzer Platform | Product Group | SKU | Item Description | Quote Doc No | Order Doc No | Deterministic Signal | Revenue Low | Revenue Base | Revenue High | GP Low | GP Base | GP High | Priority Score | Confidence | Open Order | Open Quote | Suppression Status | Next Best Action | Evidence Reference |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Account Risk | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-4a3e115566ab7f804a62c703c6b2abcb41b370b9998b9cc772d09547377beccc | OPP-02bdb580e5322d10c93ea3c813b846296a7af0bd2c3d83b66e986f3fc3d60cf5 | SER-cf19692a2afb41eaf85d18a1d1036bd833db20c512ce7855a7316dccb4646241 | Suppressed by Counter-Evidence | **** | **** | **** | Alderbrook Clinical Partners, PLLC | 44961 | HQ | University Place | WA | Northeast | Physician-Office Laboratory | High | — | — | — | — | — | — | Revenue Decline; 3 independent signals; trailing 90-day revenue $0.00 versus $2044.84; trailing 180-day revenue $2044.84 versus $1547.97; 79 days beyond expected account order date. | 1022.42 | 2044.84 | 3067.26 | — | — | — | 64.39 | Low | False | False | — | SUPPRESS | Candidate CAND-4a3e115566ab7f804a62c703c6b2abcb41b370b9998b9cc772d09547377beccc | Customer 44961 |
| Account Risk | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-58e42eb60ae57a1c25696a5dc3383780dc13edc86f9f988e0a7afa01d1e98ce9 | OPP-dede2f1d8cd9e203b014fcaa926ed5854997e34ae629e8798dddebaeec1ef576 | SER-a966b3fa27cea4d9f0bb3e2bf1409fba3d9504eee8507b2e36a2b3f1f22e172d | Needs Validation | **** | **** | **** | Alderbrook Clinical Partners, PLLC | 44961 | Vendor | University Place | WA | Northeast | Physician-Office Laboratory | High | — | — | — | — | — | — | Reduced SKU Breadth; 1 independent signal; trailing 90-day revenue $0.00 versus $885.73; trailing 180-day revenue $885.73 versus $1435.58; 62 days beyond expected account order date. | 529.95 | 1059.9 | 1589.85 | 129.15 | 258.3 | 387.44 | 56.42 | Medium | False | False | — | MANAGER_REVIEW | Candidate CAND-58e42eb60ae57a1c25696a5dc3383780dc13edc86f9f988e0a7afa01d1e98ce9 | Customer 44961 |
| Overdue Reorders | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-2f9b2c92d7c66938fc6ca333e8eb2a1019d2846d66664605289bb2e78ca5c523 | OPP-3594656468dff565fa95aee7ff6190aa3f8d46f95ceb05342bfbfdaf6104cb60 | SER-86d2e69258550e5efb108ca3e99db8dea0051656e9e6597fcbd0dda6258bd149 | Suppressed by Counter-Evidence | **** | **** | **** | Alderbrook Clinical Partners, PLLC | 44961 | Vendor | University Place | WA | Northeast | Physician-Office Laboratory | High | MicroGenics | MicroGenics | T-10015638 | Thermo Kit Creatinine Rgt DRI | — | 50709 | 4 completed purchases over 314 days; median interval 105.0 days; expected reorder 2026-06-09; High Risk by 62 days. | 324.37 | 432.5 | 540.62 | 118.11 | 157.48 | 196.85 | 63.52 | Low | False | False | — | SUPPRESS | Candidate CAND-2f9b2c92d7c66938fc6ca333e8eb2a1019d2846d66664605289bb2e78ca5c523 | Customer 44961 | Order 50709 | Item 11532 |
| Overdue Reorders | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-50db7eca8fb0fae9f47124055c5207c5da4b9d5039052d5d840bb8408cdc04d8 | OPP-918c7729c94409ffc741a74dca3573ce90bb003017afe2321893df9ea3dfd791 | SER-80dffb133a0ac682bb3ba2c3726fc43285e4e1e79ffef61ef986070089a7b102 | Suppressed by Counter-Evidence | **** | **** | **** | Alderbrook Clinical Partners, PLLC | 44961 | HQ | University Place | WA | Northeast | Physician-Office Laboratory | High | MicroGenics | MicroGenics | T-10015658 | Thermo Kit Bup Rgts CEDIA | — | 50710 | 4 completed purchases over 314 days; median interval 105.0 days; expected reorder 2026-06-09; High Risk by 62 days. | 539.28 | 719.04 | 898.8 | 23.33 | 31.11 | 38.89 | 63.46 | Low | False | False | — | SUPPRESS | Candidate CAND-50db7eca8fb0fae9f47124055c5207c5da4b9d5039052d5d840bb8408cdc04d8 | Customer 44961 | Order 50710 | Item 11536 |
| Overdue Reorders | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-7164a618f767fc7dc721e82bfe4dc1fca0d438dfb73fa764821d58a99ef2df3e | OPP-dd9fa88f953bad9ed70d83dd77dc4b88330db1977225e6ef60b82ba39e8146d9 | SER-d317c15736aad59476cc58e43e4c1163a5372c63c47c166942eb0d4f1c021e27 | Needs Validation | **** | **** | **** | Alderbrook Clinical Partners, PLLC | 44961 | HQ | University Place | WA | Northeast | Physician-Office Laboratory | High | MicroGenics | MicroGenics | T-10014585 | Thermo Kit Amphetamine Rgt DRI | — | 50710 | 4 completed purchases over 314 days; median interval 105.0 days; expected reorder 2026-06-09; High Risk by 62 days. | 277.98 | 370.64 | 463.3 | -144.43 | -115.54 | -86.66 | 60.91 | Medium | False | False | — | MANAGER_REVIEW | Candidate CAND-7164a618f767fc7dc721e82bfe4dc1fca0d438dfb73fa764821d58a99ef2df3e | Customer 44961 |
| Overdue Reorders | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-ce6328d5dc5aa0de3ecc3d1a644cde76cbc32e71a21b1115a4008427ebbab518 | OPP-1e7988326812eea3c56931816fe5f7625e166b47138b061d4d34d8a42978bc22 | SER-a6227042a1aeb2694bd7eecc190a5f82e48d0829397cd0332ddce6dd1b0ad616 | Needs Validation | **** | **** | **** | Alderbrook Clinical Partners, PLLC | 44961 | HQ | University Place | WA | Northeast | Physician-Office Laboratory | High | MicroGenics | MicroGenics | T-10014601 | Thermo Kit Opiate Rgt DRI | — | 50710 | 4 completed purchases over 314 days; median interval 105.0 days; expected reorder 2026-06-09; High Risk by 62 days. | 277.98 | 370.64 | 463.3 | -153.05 | -122.44 | -91.83 | 60.91 | Medium | False | False | — | MANAGER_REVIEW | Candidate CAND-ce6328d5dc5aa0de3ecc3d1a644cde76cbc32e71a21b1115a4008427ebbab518 | Customer 44961 |
| Overdue Reorders | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-5dfb0d93d2a1d165a881465893a95a06e900b3200f3902aba306bbcfae67cecb | OPP-da8279c6f4773748cabe08765f943697ad3f1ac3ab33163e76f1ca547e5b51cf | SER-caa7a5ae71fd27878ce8460ce669f515b685b4bb1bfcb43d89b8bc42a3bf810b | Needs Validation | **** | **** | **** | Alderbrook Clinical Partners, PLLC | 44961 | Vendor | University Place | WA | Northeast | Physician-Office Laboratory | High | MicroGenics | MicroGenics | 980929 | 980929 Indiko Wash Solution, 4.5% | — | 48945 | 3 completed purchases over 203 days; median interval 101.5 days; expected reorder 2026-02-15; High Risk by 176 days. | 138.06 | 184.08 | 230.1 | 17.26 | 23.01 | 28.76 | 60.21 | Low | False | False | — | MANAGER_REVIEW | Candidate CAND-5dfb0d93d2a1d165a881465893a95a06e900b3200f3902aba306bbcfae67cecb | Customer 44961 |
| Needs Validation | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-58e42eb60ae57a1c25696a5dc3383780dc13edc86f9f988e0a7afa01d1e98ce9 | OPP-dede2f1d8cd9e203b014fcaa926ed5854997e34ae629e8798dddebaeec1ef576 | SER-a966b3fa27cea4d9f0bb3e2bf1409fba3d9504eee8507b2e36a2b3f1f22e172d | — | **** | — | — | Alderbrook Clinical Partners, PLLC | 44961 | Vendor | — | WA | — | — | — | — | — | — | — | — | — | Reduced SKU Breadth; 1 independent signal; trailing 90-day revenue $0.00 versus $885.73; trailing 180-day revenue $885.73 versus $1435.58; 62 days beyond expected account order date. | — | 1059.9 | — | — | 258.3 | — | 56.42 | Medium | — | — | — | MANAGER_REVIEW | Candidate CAND-58e42eb60ae57a1c25696a5dc3383780dc13edc86f9f988e0a7afa01d1e98ce9 | Customer 44961 |
| Needs Validation | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-7164a618f767fc7dc721e82bfe4dc1fca0d438dfb73fa764821d58a99ef2df3e | OPP-dd9fa88f953bad9ed70d83dd77dc4b88330db1977225e6ef60b82ba39e8146d9 | SER-d317c15736aad59476cc58e43e4c1163a5372c63c47c166942eb0d4f1c021e27 | — | **** | — | — | Alderbrook Clinical Partners, PLLC | 44961 | HQ | — | WA | — | — | — | MicroGenics | — | — | — | — | — | 4 completed purchases over 314 days; median interval 105.0 days; expected reorder 2026-06-09; High Risk by 62 days. | — | 370.64 | — | — | -115.54 | — | 60.91 | Medium | — | — | — | MANAGER_REVIEW | Candidate CAND-7164a618f767fc7dc721e82bfe4dc1fca0d438dfb73fa764821d58a99ef2df3e | Customer 44961 |
| Needs Validation | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-ce6328d5dc5aa0de3ecc3d1a644cde76cbc32e71a21b1115a4008427ebbab518 | OPP-1e7988326812eea3c56931816fe5f7625e166b47138b061d4d34d8a42978bc22 | SER-a6227042a1aeb2694bd7eecc190a5f82e48d0829397cd0332ddce6dd1b0ad616 | — | **** | — | — | Alderbrook Clinical Partners, PLLC | 44961 | HQ | — | WA | — | — | — | MicroGenics | — | — | — | — | — | 4 completed purchases over 314 days; median interval 105.0 days; expected reorder 2026-06-09; High Risk by 62 days. | — | 370.64 | — | — | -122.44 | — | 60.91 | Medium | — | — | — | MANAGER_REVIEW | Candidate CAND-ce6328d5dc5aa0de3ecc3d1a644cde76cbc32e71a21b1115a4008427ebbab518 | Customer 44961 |
| Needs Validation | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-5dfb0d93d2a1d165a881465893a95a06e900b3200f3902aba306bbcfae67cecb | OPP-da8279c6f4773748cabe08765f943697ad3f1ac3ab33163e76f1ca547e5b51cf | SER-caa7a5ae71fd27878ce8460ce669f515b685b4bb1bfcb43d89b8bc42a3bf810b | — | **** | — | — | Alderbrook Clinical Partners, PLLC | 44961 | Vendor | — | WA | — | — | — | MicroGenics | — | — | — | — | — | 3 completed purchases over 203 days; median interval 101.5 days; expected reorder 2026-02-15; High Risk by 176 days. | — | 184.08 | — | — | 23.01 | — | 60.21 | Low | — | — | — | MANAGER_REVIEW | Candidate CAND-5dfb0d93d2a1d165a881465893a95a06e900b3200f3902aba306bbcfae67cecb | Customer 44961 |